Irubis receives 2.8 million euros

The start-up wants to simplify the production of medicines. This has now convinced investors such as High-Tech Gründerfonds.
The biotech Irubis has raised 2.8 million euros in its seed round. High-Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed invested in the round. The EIC Fund, the Initiative for Industrial Innovators and other business angels also participated. With the new financing, the start-up plans to expand its team and launch the next product version on the market.
Lorenz Sykora-Mirle, Alexander Geißler and Anja Müller founded Irubis in 2017. The start-up aims to automate the process development and production of biopharmaceutical drugs. The Monipa measuring system they have developed is designed to achieve this. The system can simplify the measurement of nutrients during cell cultivation and other quality parameters.
"Sensitive and robust measurements without additional time-consuming calibration are a long-awaited necessity for the production of biopharmaceutical drugs," says Laura Pedroza, Investment Manager at High-Tech Gründerfonds. "Irubis fulfills this need with its innovative and reliable Monipa technology."

Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectFYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?